Zac Santangelo - Profile and Investment Details

Investor Profile

Zac Santangelo is a Private Equity Firm based in New York City, New York, United States with a diverse investment portfolio that includes companies such as BioCryst Pharmaceuticals, Veloxis, Secura Bio, VillageMD, TRIA Beauty, SynCardia Systems, OptiNoseHalozyme Therapeutics, Recro Pharma, Sound Physicians, Agendia, Travere Therapeutics, Apollo Endosurgery, InnoPharma, Clover Health, Progenity, BioFire Diagnostics, Medicrea, . Over time, Zac Santangelo has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Zac Santangelo is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Genetics, Life Science, Information Technology (IT), Biotechnology, Genomics, Clinical Trials, Health Diagnostics, Medical, Therapeutics, Emergency Medicine, Pharmaceuticals may find it worthwhile to explore potential connections with Zac Santangelo, as their portfolio suggests a familiarity and interest in this area.

Understanding Zac Santangelo’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.